Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
767.390.04%
QQQ
716.940.03%
BTC/USD
78853.181.4998%
DIA
531.810.05%
GLD
408.130.07%
TLT
82.450.08%

Armata Pharmaceuticals Inc

ARMPAMEX
Trade with Public
Trade with Public
$5.51
0.142.61%
At close: Aug 31, 5:00 PM EST
$5.50
-0.01-0.18%
After Hours: 8:37 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Armata Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Armata Pharmaceuticals (ARMP).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

2Buy
Consensus RatingBuy# Analysts2Avg. Consensus PT$15Upside to Avg. PT+172.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Feb 23, 2026HC Wainwright & Co.Joseph PantginisPT RaiseBuy$9→$15
Jan 5, 2026Jones TradingDebanjana ChatterjeeInitiateBuy$15
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Raises Price Target to $15

HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and raises the price target from $9 to $15.
Benzinga Newsdesk

PRO
Jones Trading Initiates Coverage On Armata Pharmaceuticals with Buy Rating, Announces Price Target of $15

Jones Trading analyst Debanjana Chatterjee initiates coverage on Armata Pharmaceuticals (AMEX:ARMP) with a Buy rating and announces Price Target of $15.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Raises Price Target to $9

HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and raises the price target from $7 to $9.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved